A number of leading biomedical experts will address topics relating to precision medicine during second edition of Qatar Biobank Congress, under the theme ‘The Impact of Biobanking on Precision Medicine Initiatives.’
The conference will bring together top medical practitioners and researchers in biobanking, genomics and personalised medicine to discuss biomedical science and growing use of precision medicine to improve clinical outcomes.
The event will be held from March 14 to 15 at Qatar National Convention Centre (QNCC).
During the conference, Dr Asmaa Al Thani, Chair of Qatar Genome Programme Committee and Board Vice Chairperson of Qatar Biobank, will explain how Qatar Population Biobank Project aims to establish a research enterprise platform to achieve improvement in diagnostic and prognostic intelligence.
Topic of ‘Population Biobanks: Goals and Perspectives’, Professor Elio Riboli, Professor of Cancer Epidemiology and Prevention at Imperial College London, will highlight how population cohorts have contributed to scientific understanding of causes of chronic diseases.
